Renaissance Capital logo

Applied Genetic Technologies Priced, Nasdaq: AGTC

Biotech developing gene therapies for orphan eye diseases.

Industry: Health Care

First Day Return: +23.0%

Industry: Health Care

Biotech developing gene therapies for orphan eye diseases.
more less
IPO Data
IPO File Date 01/10/2014
Offer Price $12.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.2
Deal Size ($mm) $50
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 03/26/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $50
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Alachua, FL, United States
Founded 1999
Employees at IPO 17
Website www.agtc.com

Applied Genetic Technologies (AGTC) Performance